Fakhrul Ahsan
Cited by
Cited by
Targeting to macrophages: role of physicochemical properties of particulate carriers—liposomes and microspheres—on the phagocytosis by macrophages
F Ahsan, IP Rivas, MA Khan, AIT Suárez
Journal of controlled release 79 (1-3), 29-40, 2002
The vagina as a route for systemic drug delivery
A Hussain, F Ahsan
Journal of controlled release 103 (2), 301-313, 2005
Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine
C Thomas, A Rawat, L Hope-Weeks, F Ahsan
Molecular pharmaceutics 8 (2), 405-415, 2011
Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets
H Kadry, S Wadnap, C Xu, F Ahsan
European Journal of Pharmaceutical Sciences 135, 60-67, 2019
Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin
S Bai, C Thomas, F Ahsan
Journal of pharmaceutical sciences 96 (8), 2090-2106, 2007
Absorption enhancers in pulmonary protein delivery
A Hussain, JJ Arnold, MA Khan, F Ahsan
Journal of Controlled Release 94 (1), 15-24, 2004
Inhalable large porous microspheres of low molecular weight heparin: in vitro and in vivo evaluation
A Rawat, QH Majumder, F Ahsan
Journal of Controlled Release 128 (3), 224-232, 2008
In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals
K Nahar, N Gupta, R Gauvin, S Absar, B Patel, V Gupta, ...
European journal of pharmaceutical sciences 49 (5), 805-818, 2013
Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcome
B Patel, N Gupta, F Ahsan
European Journal of Pharmaceutics and Biopharmaceutics 89, 163-174, 2015
PEG–PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin
B Patel, V Gupta, F Ahsan
Journal of controlled release 162 (2), 310-320, 2012
Oral delivery of proteins: progress and prognostication
RB Shah, F Ahsan, MA Khan
Critical Reviews™ in Therapeutic Drug Carrier Systems 19 (2), 2002
Multi-purposable filaments of HPMC for 3D printing of medications with tailored drug release and timed-absorption
H Kadry, TA Al-Hilal, A Keshavarz, F Alam, C Xu, A Joy, F Ahsan
International journal of pharmaceutics 544 (1), 285-296, 2018
Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension
V Gupta, N Gupta, IH Shaik, R Mehvar, IF McMurtry, M Oka, ...
Journal of controlled release 167 (2), 189-199, 2013
Synthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparin
S Bai, F Ahsan
Pharmaceutical research 26, 539-548, 2009
Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparin
T Yang, A Hussain, S Bai, IA Khalil, H Harashima, F Ahsan
Journal of controlled release 115 (3), 289-297, 2006
Recent progress in dendrimer-based nanocarriers
S Bai, C Thomas, A Rawat, F Ahsan
Critical Reviews™ in Therapeutic Drug Carrier Systems 23 (6), 2006
Evaluation of human nasal RPMI 2650 cells grown at an air–liquid interface as a model for nasal drug transport studies
S Bai, T Yang, TJ Abbruscato, F Ahsan
Journal of pharmaceutical sciences 97 (3), 1165-1178, 2008
Cyclodextrins in Nasal Delivery of Low-Molecular-Weight Heparins: In Vivo and in Vitro Studies
T Yang, A Hussain, J Paulson, TJ Abbruscato, F Ahsan
Pharmaceutical research 21, 1127-1136, 2004
Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses
C Thomas, V Gupta, F Ahsan
International journal of pharmaceutics 379 (1), 41-50, 2009
Enhanced bioavailability of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats
F Ahsan, J Arnold, E Meezan, DJ Pillion
Pharmaceutical research 18, 1742-1746, 2001
The system can't perform the operation now. Try again later.
Articles 1–20